---
schema_version: "secwatch.filing_event.v1"
accession: "0001453687-24-000030"
form_type: "8-K"
ticker: "RNAC"
cik: "0001453687"
company_name: "Cartesian Therapeutics, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:13:34.326945+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cartesian Therapeutics receives Nasdaq notice of non-compliance with minimum bid price requirement

## Summary
- Nasdaq notified Cartesian on Jan 17, 2024 that its common stock closing bid price fell below $1.00 for 30 consecutive business days.
- Company has until July 15, 2024 to regain compliance; must close at or above $1.00 for 10 consecutive business days.
- If not compliant by July 15, may qualify for additional 180-day period by transferring to Nasdaq Capital Market and meeting other standards.
- Cartesian intends to monitor bid price and consider available options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001453687-24-000030
- form_type: 8-K
- ticker: RNAC
- cik: 0001453687
- company_name: Cartesian Therapeutics, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000030/0001453687-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000030/rnac-20240117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001453687-24-000030
- JSON: https://secwatch.observer/filing/0001453687-24-000030.json
- Plain text: https://secwatch.observer/filing/0001453687-24-000030.txt

## Key facts
- Listing & Compliance Notices
  Cartesian Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: January 17, 2024, Cartesian Therapeutics, Inc. (the “Company”) received a notice from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has fallen below $1.00 per share for 30 consecutive business days, the Company no longer meets the minimum bid price requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5450(a)(1). The notification from Nasdaq has no immediate effect on the listing of the Company’s Common S
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000030/0001453687-24-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.